 |
Also known as: Rilutek
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Riluzole.
No reviews have yet been submitted. Be the first to review this drug.
Jan 17, 2012 - BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), an innovative developer of adult stem cell technologies and Central Nervous System (CNS)...
Dec 14, 2011 - Metabolon, Inc., a diagnostics and services company offering the industry's leading biochemical profiling technology, announces...
Pivotal clinical study by Trophos with olesoxime in Amyotrophic Lateral Sclerosis did not reach statistical significance on the primary endpoint - Actelion...
Marseille, France – December 13, 2011 - Trophos SA announces today the results from the phase III study of Trophos’ lead compound, olesoxime, in 512...
SOUTH SAN FRANCISCO, CA--(Marketwire - Nov 30, 2011) - Cytokinetics, Incorporated (NASDAQ: CYTK) announced today positive results from the first...
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2012 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
